alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Document headings vary by document type but may contain
                    the following: the agency or agencies that issued and signed a document
the number of the CFR title and the number of each part
                      the document amends, proposes to amend, or is directly
                      related to
the agency docket number / agency internal file number
the RIN which identifies each regulatory action listed in
                      the Unified Agenda of Federal Regulatory and Deregulatory
                      Actions See the
                    Document Drafting Handbook
                    for more details.
 Department of Health and Human Services Administration for Children and Families
 *Title:*
                     April 2008 Current Population Survey Supplement on Child Support. *OMB No.:*
                     0992-0003. *Description:*
                     Collection of these data will assist legislators and policymakers in determining how effective their policymaking efforts have been over time in applying the various child support legislation to the overall child support enforcement picture. This information will help policymakers determine to what extent individuals on welfare would be removed from the welfare rolls as a result of more stringent child support enforcement efforts. *Respondents:*
                     Individuals and households. Annual Burden Estimates
Instrument
Number of 
                             respondents
Number of responses per
                             respondent
Average
                             burden 
                             hours per 
                             response
Total burden
                             hoursChild Support Survey
41,300
1
.0241666
998
 *Estimated Total Annual Burden Hours:*
                     998 *Additional Information:*
                     Copies of the proposed collection may be obtained by writing to the Administration for Children and Families, Office of Administration, Office of Information Services, 370 L'Enfant Promenade, SW., Washington, DC 20447, 
                    *Attn:*
                     ACF Reports Clearance Officer. All requests should be identified by the title of the information collection. E-mail address: 
                    *infocollection@acf.hhs.gov.* *OMB Comment:*
                     OMB is required to make a decision concerning the collection of information between 30 and 60 days after publication of this document in the 
                    **Federal Register**
                    . Therefore, a comment is best assured of having its full effect if OMB receives it within 30 days of publication. Written comments and recommendations for the proposed information collection should be sent directly to the following: Office of Management and Budget, Paperwork Reduction Project, 
                    *Fax:*
                     202-395-6974, 
                    *Attn:*
                     Desk Officer for the Administration for Children and Families. Dated: January 17, 2008. Janean Chambers, Reports Clearance Officer.


[FR Doc. 08-267  Filed 1-24-08; 8:45 am] BILLING CODE 4184-01-M
EXHIBIT 32.2

CERTIFICATION

PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY
ACT OF 2002

(SUBSECTIONS (a) AND (b) OF SECTION 1350,
CHAPTER 63 OF TITLE 18,

UNITED STATES CODE)



Pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of Section 1350, chapter 63 of Title 18, United States Code), the undersigned
officer of Mimvi, Inc. (the “Company”), does hereby certify with respect to the Quarterly Report of the Company on
Form 10-Q for the period ended March 31, 2013 as filed with the Securities and Exchange Commission on the date hereof (the “Report”),
to the best of the undersigned’s knowledge that:



(1) The Report fully complies with the requirements
of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and



(2) The information contained in the Report fairly
presents, in all material respects, the financial condition and results of operations of the Company.



Date:     May 20, 2013



| | /s/ Kevin J. Conner                         
| | --------------------------------------------
| | Kevin J. Conner                             
| | Chief Financial Officer                     
| | (Principal Accounting and Financial Officer)
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

The meting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         Allergy, Immunology, and Transplantation Research Committee.                    

*Date:*                         February 12-13, 2008.                    

*Time:*                         8:30 a.m. to 5 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         Doubletree Hotel, 1515 Rhode Island Avenue, NW., Washington, DC 20005.                    

*Contact Person:*                         Katrin Eichelberg, PhD, Scientific Review Officer, Scientific Review Program, Division of Extramural Activities, NIAID/NIH/DHHS, 6700B Rockledge Drive, MSC 7616, Bethesda, MD 20892, (301) 496-0818,                         *keichelberg@niaid.nih.gov.*

This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle.

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS)

Dated: January 17, 2008.

Jennifer Spaeth,

Director, Office of Federal Advisory Committee Policy.

[FR Doc. 08-306  Filed 1-25-08; 8:45 am]

BILLING CODE 4140-01-M
Monday – May 19, 2003 

8:00 a.m. - 8:30 a.m. 

8:30 a.m. – 9:00 a.m. 

9:00 a.m. - 9:30 a.m. 

9:30 a.m. - 10:00 a.m. 

10:00 a.m. – 10:15 a.m. 

10:15 a.m. – 11:15 a.m. 

11:15 a.m. - 12:00 a.m. 

12:00 a.m. – 1:30 p.m. 

1:30 p.m. – 2:15p.m. 

2:15 p.m. – 3:00 p.m. 

3:00 p.m. - 3:15 p.m. 

3:15 p.m. - 3:30 p.m. 

3:30 p.m. – 4:15 p.m. 

4:15 p.m. – 5:00 p.m. 

5:00 p.m. 

Draft Agenda
 

Advisory Board on Radiation and Worker Health
 

Garden Plaza Hotel
 

215 South Illinois Avenue
 

Oak Ridge, Tennessee 37830
 

(865) 481-2468
 

May 19 - 20, 2003
 

Registration and Welcome Dr. Paul Ziemer, Chair 

Dr. John Howard, Director NIOSH 

Mr. Larry Elliott, Executive Secretary 

Program Status Report Mr. David Sundin, NIOSH - OCAS 

DOL Program Status Report Mr. Shelby Hallmark, DOL, OWCP 

Recent IREP Modifications and Mr. Brian Thomas, SENES Oak Ridge, Inc.

 Recommended Updates Dr. Iulian Apostoaei, SENES Oak Ridge, Inc. 

Break 

The UK Compensation Scheme Mr. Michael Lewis, Mr. Andy Slovac, 

 For Radiation Linked Diseases Mr. John Billard, BNFL 

Working Group Report Mr. Mark Griffon

 Dose Reconstruction Review Process 

Lunch 

Future Consideration of Dr. Owen Hoffman, SENES Oak Ridge, Inc.

 Uncertainty in IREP 

A Refresher and Update Dr. David Kocher, SENES Oak Ridge, Inc.

 On REFs Assumed in IREP 

Break 

NAS Report on Review of DTRA Mr. Dennis M. Schaeffer

 Dose Reconstruction Program 

Board Discussion/Working Session 

Review Process of Completed Dose Reconstructions 

Public Comment Period 

Adjourn 

***Agenda items are subject to change as priorities dictate*** 

Draft Agenda 
Tuesday – May 20, 2003 

8:00 a.m. - 8:30 a.m. 

8:30 a.m. - 9:15 a.m. 

9:15 a.m. - 10:30 a.m. 

10:30 a.m. – 10:45 a.m. 

10:45 a.m. – 11:15.m. 

11:15 a.m. - 12:00 p.m. 

12:00 p.m. - 1:00 p.m. 

1:00 p.m. – 2:00 p.m. 

2:00 p.m. 

Advisory Board on Radiation and Worker Health
 

Garden Plaza Hotel
 

215 South Illinois Avenue
 

Oak Ridge, Tennessee 37830
 

(865) 481-2468 

May 19 - 20, 2003 

Registration and Welcome Dr. Paul Ziemer, Chair 

Mr. Larry Elliott, Executive Secretary 

Ethics for Special Government Ms. Paula Kocher, HHS, OGC

 Employees 

Epidemiological Research Dr. Mary Schubauer-Berigan, NIOSH 

of DOE Workers - Status Dr. David Utterback, NIOSH 

Break 

Board Discussion/Working Session 

Review Process of Completed Dose Reconstructions 

Public Comment Period 

Lunch 

Review/Approval of Minutes, Ms. Cori Homer, NIOSH

 Board Work Schedule Dr. Paul Ziemer, Chair

 & Administrative Housekeeping Mr. Larry Elliott, Executive Secretary 

Adjourn 

***Agenda Items are subject to change as priorities dictate***
This memorandum opinion was not selected for publication in the New Mexico Appellate Reports. Please see Rule 12-405 NMRA for restricti ons on the citation of unpublished memorandum opinions. Please also note that this electronic memorandum opinion may contain computer-generated errors or other deviations from the official paper version filed by the Court of Appeals and does not include the filing date.
IN THE COURT OF APPEALS OF THE STATE OF NEW MEXICO 1 BRENDA C. PRICE, 2 Plaintiff-Appellant, 3 v. No. A-1-CA-36357 4 JP MORGAN CHASE, NA; CHASE HOME 5 FINANCE; BANK OF AMERICA, NA; S&S 6 FINANCIAL GROUP, LLC; LINDA 7 SCHOLLER; and JEANIE SOULE-MEIHOUS, 8 Defendants-Appellees. 9 APPEAL FROM THE DISTRICT COURT OF TAOS COUNTY 10 Jeff McElroy, District Judge 11 Brenda C. Price 12 Taos, NM 13 Pro Se Appellant 14 Weinstein & Riley, P.S. 15 Jason Collis Bousliman 16 Albuquerque, NM 17 for Appellees 18 MEMORANDUM OPINION 192 SUTIN, Judge. 1 {1} Summary affirmance was proposed for the reasons stated in the notice of 2 proposed summary disposition. No memorandum opposing summary affirmance has 3 been filed and the time for doing so has expired. 4 {2} AFFIRMED. 5 {3} IT IS SO ORDERED. 6

__________________________________ 7 JONATHAN B. SUTIN, Judge 8 WE CONCUR: 9

___________________________________ 10 TIMOTHY L. GARCIA, Judge 11

___________________________________ 12 J. MILES HANISEE, Judge 13
[Federal Register Volume 73, Number 13 (Friday, January 18, 2008)]
[Notices]
[Page 3472]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 08-156]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel, Biodefense Therapeutics.
    Date: February 11-13, 2008.
    Time: 8 a.m. to 6 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 
Wisconsin Avenue, Bethesda, MD 20814.
    Contact Person: Ellen S. Buczko, PhD, Scientific Review Officer, 
Scientific Review Program, Division of Extramural Activities, 
National Institutes of Health/NIAID, 6700B Rockledge Drive, MSC 
7616, Bethesda, MD 20892-7616, 310-451-2676, <a href="/cdn-cgi/l/email-protection#b3d6d1c6d0c9d8dc82f3dddad2dad79ddddadb9dd4dcc5"><span class="__cf_email__" data-cfemail="690c0b1c0a1302065829070008000d47070001470e061f">[email protected]</span></a>.

    Name of Committee: Microbiology, Infectious Diseases and AIDS 
Initial Review Group, Microbiology and Infectious Diseases B 
Subcommittee.
    Date: February 13-14, 2008.
    Time: 8 a.m. to 6 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Holiday Inn Georgetown, 2101 Wisconsin Avenue, NW., 
Washington, DC 20007.
    Contact Person: Gary S. Madonna, PhD, Scientific Review Officer, 
Scientific Review Program, Division of Extramural Activities, 
National Institutes of Health/NIAID, 6700B Rockledge Drive, MSC 
7616, Bethesda, MD 20892, 301-496-3528, <a href="/cdn-cgi/l/email-protection#bbdcd68a89ccfbd5d2d395dcd4cd"><span class="__cf_email__" data-cfemail="e48389d5d693a48a8d8cca838b92">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: January 11, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 08-156 Filed 1-17-08: 8:45 am]
BILLING CODE 4140-01-M


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
Exhibit 32.1

                    CERTIFICATION OF CHIEF EXECUTIVE OFFICER
                       PURSUANT TO 18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Sienna Resources, Inc. (the
"Company") on Form 10-Q for the period ending June 30, 2008 as filed with the
Securities and Exchange Commission on the date hereof (the "Report"), I, Julie
Carter, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C.
ss.1350, as adopted pursuant to ss.906 of the Sarbanes-Oxley Act of 2002, that:

     (1)  The Report fully complies with the requirements of section 13(a) or
          15(d) of the Securities Exchange Act of 1934; and

     (2)  The information contained in the Report fairly presents, in all
          material respects, the financial condition and result of operations of
          the Company.

IN WITNESS WHEREOF, the undersigned has executed this certification as of the
12th day of August, 2008.


/s/ Julie Carter
---------------------------
Chief Executive Officer
| 1.   | The Report fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934; and |
|----------------|--------------------------------------------------------------------------------------------------------------|

| 2.   | The information contained in the Report fairly presents, in all material respects, the consolidated financial condition of the Company as of the dates presented and the consolidated result of operations of the Company for the periods presented. |
|----------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   By: |   /s/ Zandra Grace Hernandez                                     |
|-----------------|----------------------------------------------------------------------------|
|  Name:     |  Zandra Grace Hernandez                                               |
|  Title:    |  Principal Executive Officer,Principal Financial Officer and Director |
|  Date:     |  October 15, 2010                                                     |
AGENDA 

Advisory Board on Radiation and Worker Health 

Meeting of the Fernald Work Group

September 3, 2014

Cincinnati Airport Marriott

2395 Progress Dr., Hebron, KY 41048 

Phone (859) -586-0166

Conference Call Number: 1-866-659-0537 Participant Pass Code: 9933701 

9:00 a.m. Eastern Time: Welcome and roll-call/introductions 

Work Group Discussion 

• Follow up on February 3, 2014 letter concerning bioassay monitoring at Fernald and implications 

for the subcontractor SEC end date (83 vs. 85)

o “Due diligence” in determining representativeness of the 1984-1985 data: In order to gain a 

better perspective on whether the 84-85 data set is reasonably representative of all 

subcontractor jobs during that period, NIOSH agreed at the 4/15 WG teleconference to try to 

determine the company affiliation for subcontractors during the first couple of years of 

Westinghouse’s tenure (86-87) and try to illuminate what these subcontracting companies 

did.

• NIOSH presents overview of new post-SEC thorium methodology and in vivo coworker model for 

1979-1988 timeframe

o SC&A to offer preliminary questions/responses

• Continued issues resolution for SC&A site profile review findings

• Work Group plans for next meeting later in the year to discuss SC&A review of post-SEC thorium 

model

Adjourn
EXHIBIT
32.2
 
 STATEMENT
REQUIRED BY 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT
 TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
 
 In
connection with the Quarterly Report on Form 10-Q of Man Shing Agricultural
Holdings, Inc, (the "Company") for the three and six months ended December 31,
2009, as filed with the Securities and Exchange Commission on the date hereof
(the "Report"), I, Kenny Chow, Chief Financial Officer, of the Company, certify
that:
  
 *   the
Report fully complies with the requirements of Section 13(a) or 15(d) of the
Securities Exchange Act of 1934; and
 
 *   information
contained in the Report fairly presents, in all material respects, our
consolidated financial condition and results of operations.
 
 
 /s/ Kenny
Chow
 Kenny
Chow
 Chief
Financial Officer
 
 
 Date:
February 11, 2010
 
 
 This
certification accompanies this Report pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by the
Sarbanes-Oxley Act of 2002, be deemed filed by us for purposes of Section 18 of
the Securities Exchange Act of 1934, as amended.
Exhibit 32.1



CERTIFICATION PURSUANT TO18 U.S.C. Section 1350,AS ADOPTED PURSUANT TOSECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report ofAlto Group Holdings Inc.(the "Company") on Form 10-Q for the period ended February 28, 2009 as filed with the Securities and Exchange Commission on the date here of (the "report"), I, Tareq Hinawy, Chief Executive Officer and Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

| | (1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and                                
| | --- | -----------------------------------------------------------------------------------------------------------------------------------------------------
| |     |                                                                                                                                                      
| | (2) | The information contained in this Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated this 13thday of April, 2009.

TAREQ HINAWYTareq HinawyChief Executive Officer and Chief Financial Officer












---
### THE THIRTEENTH COURT OF APPEALS
13
- 19
- 00456
- CV Carrie Scruggs v. Rockport Terminals, LLC On Appeal from the 36th District Court of Aransas County , Texas Trial Cause No. A
- 19
- 0171
- CV
- A
JUDGMENT THE THIRTEENTH COURT OF APPEALS, having considered thi s cause on appeal, concludes the appeal should be DISMISSED

. The Court orders the appeal DISMISSED in accordance with its opinion

. Costs of the appeal are taxed against the party inc urring same. We further order this decision certified below for observanc e. October 1 , 20 20
NOTE: Pursuant to Fed. Cir. R. 47.6, this disposition is 

not citable as precedent. It is a public record. 

United States Court of Appeals for the Federal Circuit 

05-3240 

LINDA M. OLLADO, 

Petitioner, 

 v. 

MERIT SYSTEMS PROTECTION BOARD, 

Respondent. 

 __________________________ 

 DECIDED: December 9, 2005 

 __________________________ 

Before NEWMAN, MAYER, and SCHALL, Circuit Judges. 

PER CURIAM. 

Linda M. Ollado appeals the final decision of the Merit Systems Protection Board 

that dismissed her petition for review as untimely filed without a showing of good cause 

for the delay. Ollado v. Office of Pers. Mgmt., SE0831030274-I-3 (MSPB June 1, 

2005). Because the board did not abuse its discretion or misapply the law, we affirm. 

A petition for review by the board must be filed within thirty-five days of the 

administrative judge’s initial decision unless good cause is shown for the delay. 

5 C.F.R. §§ 1201.114(d), (f) (2004). In this case, the administrative judge issued an 
initial decision on August 18, 2004. Ollado, however, did not file a petition for review

until November 17, 2004, which was beyond the thirty-five day deadline. As such, the 

initial decision became the final decision of the board on September 22, 2004. See id.

§ 1201.113. 

“To establish good cause for a filing delay, an appellant must show that the delay

was excusable under the circumstances and that the appellant exercised due diligence 

in attempting to meet the filing deadline.” Zamot v. Merit Sys. Prot. Bd., 332 F.3d 1374,

1377 (Fed. Cir. 2003) (citing Phillips v. United States Postal Serv., 695 F.2d 1389, 1391 

(Fed. Cir. 1982)). In addition, “the waiver of a regulatory time limit based on a showing 

of good cause ‘is a matter committed to the Board’s discretion and . . . this court will not

substitute its own judgment for that of the Board.’” Id. (quoting Mendoza v. Merit Sys. 

Prot. Bd., 966 F.2d 650, 653 (Fed. Cir. 1992) (en banc)). Ollado did not set forth any 

evidence establishing good cause for the delay; therefore, the board did not abuse its

discretion.

05-3240 2